In This Section
Back to Grantees
Loading...
Collaborations for Smoking Cessation: The 2019 AACR-Johnson & Johnson Lung Cancer Innovation Science Grants

Collaborations for Smoking Cessation: The 2019 AACR-Johnson & Johnson Lung Cancer Innovation Science Grants

In recognition of the need to advance the science of lung cancer prevention and interception, the 2019 AACR-J&J Lung Cancer Innovation Science Grants program awarded grants to two multi-institutional teams whose multifaceted projects seek to understand how an individual’s genetics may affect smoking-related behaviors and quit attempts, as well as to develop clinically actionable smoking cessation strategies that will improve patient outcomes.

AACR-Bristol Myers Squibb Midcareer Female Investigator Grants: Closing Funding Gaps and Expanding Research

AACR-Bristol Myers Squibb Midcareer Female Investigator Grants: Closing Funding Gaps and Expanding Research

The AACR-Bristol Myers Squibb Midcareer Female Investigator Grant is the AACR’s first dedicated funding mechanism for midcareer scientists, as well as the first dedicated for women. The goal is to ensure that midcareer female researchers have the resources they need to successfully establish themselves as independent investigators with productive research labs.

AACR Annual Meeting 2021: NextGen Stars Sessions Featured Research from Early-career Investigators

AACR Annual Meeting 2021: NextGen Stars Sessions Featured Research from Early-career Investigators

Since 2014, the American Association for Cancer Research (AACR) has invited early-career investigators to apply to the NextGen Stars program, which provides awardees the opportunity to present their research on a global stage at the AACR Annual Meeting.   The enhanced visibility granted by the NextGen Stars program has helped prior recipients establish collaborations and receive constructive...

AACR – J&J Lung Cancer Innovative Science Grants: Cutting-Edge Approaches to Cut Down Cancer Risk

AACR – J&J Lung Cancer Innovative Science Grants: Cutting-Edge Approaches to Cut Down Cancer Risk

Lung cancer remains the number one cause of cancer-related death. This persistent dismal prognosis has been largely attributed to late-stage diagnosis, when 5-year survival rates are less than 5%. Although the potential of lung cancer screening to reduce lung cancer-related mortality has been demonstrated, there remains a need for more effective and less invasive early detection methods. The AACR-Johnson & Johnson Lung Cancer Innovative Science Grants are fueling...